Xolair Warning Label

Updated

Both the FDA and Health Canada have issued warnings about this pharmaceutical.

FDA Proposes to Strengthen Label Warning for Xolair
February 21, 2007 - "The Food and Drug Administration (FDA) announced that it has requested Genentech, Inc. add a boxed warning to the product label for omalizumab, marketed as Xolair. The boxed warning emphasizes that Xolair, used to treat patients with asthma related to allergies, may cause anaphylaxis. Anaphylaxis may include trouble breathing, chest tightness, dizziness, fainting, itching and hives, and swelling of the mouth and throat. In addition, FDA has asked Genentech to revise the Xolair label and provide a Medication Guide for patients to strengthen the existing warning for anaphylaxis."
http:/­/­www.fda.gov/­NewsEvents/­Newsroom/­PressAnnouncements/­2007/­ucm108850.htm

Early Communication about an Ongoing Safety Review of Omalizumab (marketed as Xolair)
July 16, 2009 - "FDA is evaluating interim safety findings from an ongoing study of Xolair (omalizumab) that suggests an increased number of cardiovascular and cerebrovascular adverse events in a group of patients using Xolair compared to a group of patients not given the drug (control group).

Xolair is approved for use by adults and adolescents (12 years of age and above) with moderate to severe persistent asthma who test positive for reactivity to a perennial airborne allergen, and whose symptoms are inadequately controlled with inhaled corticosteroids.

The ongoing study, titled Evaluating the Clinical Effectiveness and Long-Term Safety in Patients with Moderate to Severe Asthma (EXCELS), is an observational study of approximately 5000 Xolair treated patients and a control group of approximately 2500 non-Xolair treated patients. The primary objective of the EXCELS study is to assess the long-term safety profile of Xolair in patients followed for 5 years. Study patients are 12 years of age and older with moderate to severe persistent asthma and who have a positive skin test or blood test for an aeroallergen.

The interim data, submitted by the manufacturer of Xolair (Genentech), suggests a disproportionate increase in ischemic heart disease, arrhythmias, cardiomyopathy and cardiac failure, pulmonary hypertension, cerebrovascular disorders, and embolic, thrombotic and thrombophlebitic events in patients treated with Xolair compared to the control group of patients not given the drug.

FDA is not recommending any changes to the prescribing information for Xolair and is not advising patients to stop taking Xolair at this time. Until the evaluation of the EXCELS study is completed, healthcare providers and patients should be aware of the risks and benefits described in the prescribing information, as well as the new information from the ongoing EXCELS study that may suggest a risk of cardiovascular and cerebrovascular adverse events."
http://www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafety...ucm172218.htm

2 Replies

Earliest Newest Votes
1

I started taking Xolair in June 2009. I am having short term memory loss, cannot concentrate, ankles are sore, breating is worse than before, I am more exhausted than before. I never read some of these adverse reactions before I read your question. I have CODP. Thank you.

Was this helpful? 0
2

I had many adverse reactions... My first issue was severe shoulder pain. noone associated it with Xolair. No physical injury. Most recent swelling of the legs and ankles, tired all the time, couldn't walk up the driveway infront of my house without getting really winded. I stopped and my overall health is improving. There were numerous side effects, too many to mention.

Was this helpful? 0

More Discussions:

Warning: Chinese Diet Pills May Contain Traces Of Danger

Below is an article from Stephanie Marcus, who has done some research into the recently popular Chinese Diet Pills. They...

13 REPLIES
Warning To Suboxone Users Of Potential Allergy to Sufa Drugs

i kept getting sick after every strip or tablet of suboxone i took.i was a chronic pain patient for 17 yrs. and a former...

3 REPLIES
WARNING About excess dosage of gabapentin

I ha spinal stenosis and neuropathy in my left foot. The ain clinin had been prescribed me 800mg 4x a day for 7 years. W...

3 REPLIES
warnings side effects-uses-precautions for ferrous sulfate[iron]

prescripion drug i9nformation ## does anyone know what Providual is and what is it used to treat? Thanks ## Ferrous Sulf...

2 REPLIES
Warnings regarding Oxetol

Recently it was fiagnosed that I have partial complex seizures hence the neurologist prescribed Oxetol (to be gradually ...

2 REPLIES
WARNING ABOUT SUBOXONE!

WE are all trying to kick that nasty opiate addiction. We are killing ourselves w oxy, H, etc. But all my online researc...

2 REPLIES
Warning web site rxvipshops com

They tell you it ships from U.S. 3-5 days then after you place a order they tell you it ships from India. ## Hi jaycees,...

2 REPLIES
WARNING Sibrutamine

I took sibrutamine and it did an amazing job. I was losing weight fast and lost 30 pounds in no time loved the results. ...

1 REPLY
New Warning and Precautions from FDA

My wife has been taking Multaq for 9 months. In January, she was hospitalized with renal failure and treated with IV'...

4 REPLIES
Ampyra Warning

I have to inform everyone I can about this issue. My doctor wants me to take Ampyra and she handed me the Ampyra Patient...

9 REPLIES